PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

FYVDGOCCFDKYOR-OEQCKVCZSA-N

InChI Key

FYVDGOCCFDKYOR-OEQCKVCZSA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:191365

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Plasma_vs_WY-14,643_Plasma
• Control_12h_vs_Toxocara canis_12h
• Control_12h_vs_Toxocara canis_12h
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• BSA_Control_vs_AA